• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Position paper of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), and the Italian Study Group of Diabetes in pregnancy: Metformin use in pregnancy
ConclusionsMetformin may represent a therapeutic option in selected women with obesity, PCOS, GDM, T2DM, and in women undergoing ART. However, more research is required specifically on the long-term effects of in utero exposition to metformin.
Source: Acta Diabetologica - July 4, 2023 Category: Endocrinology Source Type: research

The Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes Mellitus: A Brief Report
CONCLUSION: We evaluated the effects of the COVID-19 lockdown on glucometabolic control in patients with background well-controlled T2D. We found that the lockdown had no adverse effects on metabolic profile regardless of background clinical characteristics and antihyperglycemic management. Despite limitations due to the nature of this study (sample size, retrospective observation, lack of data on lifestyle changes in our patients' everyday lives), T2D patients managed in our Diabetes Centers faced the lockdown-related restrictions without any detrimental consequence.PMID:36644863 | DOI:10.2174/1871530323666230112165948
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - January 16, 2023 Category: Endocrinology Authors: Alfredo Vozza Erasmo Porfido Alessandra Delvino Carlo Custodero Giuseppe Lisco Vincenzo Triggiani Cosimo Tortorella Giuseppina Piazzolla Source Type: research

Older Adults with Type 2 Diabetes Treated with Metformin: AME-MET Study; A Multicentric Real-world Study in Italy
CONCLUSIONS: In this real-world study, the minimum daily effective dose of metformin was prescribed in more than half of T2DM older outpatients.PMID:36380441 | DOI:10.2174/1871530323666221115091621
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - November 16, 2022 Category: Endocrinology Authors: Elena Castellano Borretta Giorgio Attanasio Roberto Boriano Alberto Agrimi Daniela Argese Nicola Crescenti Cassandra Disoteo Olga Fusco Alessandra Gabellieri Enrico Guglielmi Rinaldo Lisco Giuseppe Lo Pomo Feliciano Nizzoli Maurizio Panico Annalisa Pirali Source Type: research

Fight Aging! Newsletter, August 8th 2022
In conclusion, aging research will benefit from a better definition of how specific regulators map onto age-dependent change, considered on a phenotype-by-phenotype basis. Resolving some of these key questions will shed more light on how tractable (or intractable) the biology of aging is. Does Acarbose Extend Life in Short Lived Species via Gut Microbiome Changes? https://www.fightaging.org/archives/2022/08/does-acarbose-extend-life-in-short-lived-species-via-gut-microbiome-changes/ Acarbose is one of a few diabetes medications shown to modestly slow aging in short-lived species. Researchers here take a ...
Source: Fight Aging! - August 7, 2022 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network
CONCLUSION: This retrospective study covers an unexplored area of research in patients with thalassemia and GD. Oral GLAs appear to be safe and effective for the treatment of diabetes mellitus in patients with thalassemia, and can achieve adequate glycemic control for a substantial period of time.PMID:35546014 | DOI:10.23750/abm.v93i2.12056
Source: Acta Bio-Medica : Atenei Parmensis - May 12, 2022 Category: General Medicine Authors: Vincenzo De Sanctis Ashraf Soliman Ploutarchos Tzoulis Shahina Daar Antonis Kattamis Polyxeni Delaporta Mehran Karimi Mohamed A Yassin Tahereh Zarei Forough Saki Katia Sapunarova Atanas Banchev Maria Concetta Galati Giuseppe Raiola Giuseppe Messina Saveri Source Type: research

Pages: 1  2